Category: Congress Info

The Targeting Phage Therapy 2023 Best Scientific Contribution award was discerned to:

Amanda (Curtis) Burkardt, CEO of PHIOGEN, USA

Ms. Burkardt was awarded for creating patient ready products in a remedy ready world.

Spun-off from of one of the US’s only phage therapy cores, TAILOR Labs at Baylor College of Medicine, an ambitious new biotech venture PHIOGEN has developed a world-first technology platform that mobilizes the natural power of bacteriophages to tackle critical and life-threatening infections and marks a significant medical breakthrough for countering the global threat of antimicrobial resistance.

The proprietary first-of-its-kind technology platform is able to discover and screen at-scale naturally occurring bacteriophages, singling out those with elite bacteria-fighting abilities, and directing biological changes to evolve the phages into antimicrobials that overcome resistance. This opens up a new business model for phage therapy as the group is able to create products that treat populations of people instead of on a per patient basis.

Accepting the award, Amanda said: “We must give credit to the incredible team at TAILOR Labs where none of this would be possible without their tireless efforts and the support of Baylor College of Medicine and BCM Ventures. This event has been an exceptional springboard for our launch, and I can’t stress enough how this win is not just a win for us, but a win for all who are looking to push phage forward.”

You can get better introduce to PHIOGEN in the Targeting Phage Therapy 2023 Replay and Abstracts Book.

Targeting Phage Therapy 2023 Congress
6th World Conference
June 1-2, 2023 – Paris, France

25+ posters will be presented during Targeting Phage Therapy 2023 on June 1-2.  Access the full list of posters.

Iddo Nadav Weiner, VP of Research at BiomX, Israel presented a short oral talk entitled “A Phase 1b/2a Randomized, Double-blind, Placebo-controlled Study Evaluating Nebulized Phage Therapy in Cystic Fibrosis Subjects With Chronic Pseudomonas Aeruginosa Pulmonary Infection ” during Targeting Phage Therapy 2023 on June 1-2 in Paris.

Dr. Weiner will describe the development of a phage cocktail designed to efficiently target a wide range of P. aeruginosa strains. The phage cocktail when administered to nine cystic fibrosis patients chronically infected with P. aeruginosa in a phase 1b/2a double-blinded placebo-controlled clinical trial, was demonstrated to be safe and well-tolerated.

Furthermore, patients treated with phage showed a dramatic reduction in P. aeruginosa sputum density compared to the placebo group. 

You can learn more about Dr. Weiner’s and this BiomX phage cocktail in Targeting Phage Replay and/or Abstracts Book.

Conference program.

Targeting Phage Therapy 2023
6th World Conference
June 1-2, 2023 – Paris, France
LinkedIn | Facebook| Website

Adam Ostrowski, Cellexus, United Kingdom presented a short oral talk entitled “Implementing GMP Manufacturing for Phage Therapy” during Targeting Phage Therapy 2023 on June 1-2 in Paris.

The CellMaker single use, airlift bioreactor is an ideal fermentation system for phage production in a GMP environment. The patented airlift technology provides excellent mixing and aeration kinetics and combined with the ease of use, lets the CellMaker system help fermentation scientists and upstream process engineers achieve better phage production yields to the standards required for release into the clinic.

You can benefit from Dr. Ostrowski’s experience and learn more about the CellMaker in Targeting Phage Replay and/or Abstracts Book.

Conference program.

Targeting Phage Therapy 2023
6th World Conference
June 1-2, 2023 – Paris, France
LinkedIn | Facebook| Website

Targeting Phage 2023: Questions, Controversies, & What is Next?

Targeting Phage Therapy 2023 will highlight the recent innovations and clinical applications of phages, validation and limitations. Targeting Phage Therapy 2023 will also cover how phages will transform the medicine of tomorrow.

More Than Just Scientific Knowledge at Targeting Phage Therapy 2023:

The regulation and legal aspects will also be debated and a kind of consensus will be elaborated at the end of the meeting. A discussion will also be held on how to overcome barriers between experts, academics, industrials, and regulators.

The chairman, Prof. Marvin Edeas, Institut Cochin, INSERM U1016, Université de Paris, stated: “Our aim is not to only gather speakers, but we must find an issue to bring phage therapy to another level. Each speaker will highlight where we are now and where we are heading. I believe that phages will be the hottest topic not only to combat infection and antibiotic resistance, but also to modulate our microbiota.”

Read the full press release on eurekalert.

Access the conference program.

Targeting Phage Therapy 2023
6th World Conference
June 1-2, 2023 – Paris, France
LinkedIn | Facebook| Website